Browse by UCL people
Group by: Type | Date
Jump to: Article
Number of items: 17.
Article
Bird, SM;
Strang, J;
Ashby, D;
Podmore, J;
Robertson, JR;
Welch, S;
Meade, AM;
(2017)
External data required timely response by the Trial Steering-Data Monitoring Committee for the NALoxone InVEstigation (N-ALIVE) pilot trial.
Contemporary Clinical Trials Communications
, 5
pp. 100-106.
10.1016/j.conctc.2017.01.006.
|
 |
|
Blinman, PL;
Davis, ID;
Martin, A;
Troon, S;
Sengupta, S;
Hovey, E;
Coskinas, X;
... Stockler, MR; + view all
(2018)
Patients' preferences for adjuvant sorafenib after resection of renal cell carcinoma in the SORCE trial: what makes it worthwhile?
Annals of Oncology
, 29
(2)
pp. 370-376.
10.1093/annonc/mdx715.
|
|
Choodari-Oskooei, B;
Bratton, DJ;
Gannon, MR;
Meade, AM;
Sydes, MR;
Parmar, MKB;
(2020)
Adding new experimental arms to randomised clinical trials: Impact on error rates.
Clinical Trials
10.1177/1740774520904346.
(In press).
|
|
|
Eisen, T;
Frangou, E;
Oza, B;
Ritchie, AWS;
Smith, B;
Kaplan, R;
Davis, ID;
... Meade, A; + view all
(2020)
Adjuvant Sorafenib for Renal Cell Carcinoma at Intermediate or High Risk of Relapse: Results From the SORCE Randomized Phase III Intergroup Trial.
Journal of Clinical Oncology
, 38
(34)
pp. 4064-4075.
10.1200/jco.20.01800.
|
|
Kwakman, JJM;
van Kruijsdijk, RCM;
Elias, SG;
Seymour, MT;
Meade, AM;
Visseren, FLJ;
Punt, CJA;
(2019)
Choosing the right strategy based on individualized treatment effect predictions: combination versus sequential chemotherapy in patients with metastatic colorectal cancer.
Acta Oncologica
, 58
(3)
pp. 326-333.
10.1080/0284186X.2018.1564840.
|
|
|
Lawrence, NJ;
Martin, A;
Davis, ID;
Troon, S;
Sengupta, S;
Hovey, E;
Coskinas, X;
... Stockler, MR; + view all
(2018)
What Survival Benefits are Needed to Make Adjuvant Sorafenib Worthwhile After Resection of Intermediate - or High-Risk Renal Cell Carcinoma? Clinical Investigators' Preferences in the SORCE Trial.
Kidney Cancer
, 2
(2)
pp. 123-131.
10.3233/KCA-180038.
|
|
|
Lawrence, NJ;
Martin, A;
Davis, ID;
Troon, S;
Sengupta, S;
Hovey, E;
Coskinas, X;
... Stockler, MR; + view all
(2020)
Individualised Predictions of the Survival Benefit Due to Adjuvant Therapy in a Randomised Trial of Sorafenib after Nephrectomy for Localised Renal Cell Carcinoma.
Kidney Cancer
, 4
(4)
pp. 185-195.
10.3233/KCA-200104.
|
|
|
Madi, A;
Fisher, D;
Maughan, TS;
Colley, JP;
Meade, AM;
Maynard, J;
Humphreys, V;
... Cheadle, JP; + view all
(2018)
Pharmacogenetic analyses of 2183 patients with advanced colorectal cancer; potential role for common dihydropyrimidine dehydrogenase variants in toxicity to chemotherapy.
European Journal of Cancer
, 102
pp. 31-39.
10.1016/j.ejca.2018.07.009.
|
|
Meade, A;
Oza, B;
Frangou, E;
Smith, B;
Bryant, H;
Kaplan, R;
Choodari-Oskooei, B;
... Parmar, MKB; + view all
(2021)
RAMPART: A model for a regulatory-ready academic-led phase III trial in the adjuvant renal cell carcinoma setting.
Contemporary Clinical Trials
, 108
, Article 106481. 10.1016/j.cct.2021.106481.
|
|
|
Meade, Angela;
Frangou, Elena;
Choodari-Oskooei, Babak;
Larkin, James;
Powles, Tom;
Stewart, Grant D;
Albiges, Laurence;
... Parmar, Mahesh KB; + view all
(2024)
Adapting the design of the ongoing RAMPART trial in response to external evidence: An example for trials which take many years to run and report.
Contemporary Clinical Trials Communications
, 42
, Article 101381. 10.1016/j.conctc.2024.101381.
|
 |
|
Meade, AM;
Bird, SM;
Strang, J;
Pepple, T;
Nichols, LL;
Mascarenhas, M;
Choo, L;
(2017)
Methods for delivering the UK's multi-centre prison-based naloxone-on-release pilot randomised trial (N-ALIVE): Europe's largest prison-based randomised controlled trial.
Drug and Alcohol Review
10.1111/dar.12592.
(In press).
|
|
|
Oza, B;
Frangou, E;
Smith, B;
Bryant, H;
Kaplan, R;
Choodari-Oskooei, B;
Powles, T;
... Meade, A; + view all
(2021)
RAMPART: A phase III multi-arm multi-stage trial of adjuvant checkpoint inhibitors in patients with resected primary renal cell carcinoma (RCC) at high or intermediate risk of relapse.
Contemporary Clinical Trials
, 108
, Article 106482. 10.1016/j.cct.2021.106482.
|
|
|
Oza, Bhavna;
Eisen, Tim;
Frangou, Eleni;
Stewart, Grant D;
Bex, Axel;
Ritchie, Alastair WS;
Kaplan, Rick;
... Meade, Angela; + view all
(2022)
External Validation of the 2003 Leibovich Prognostic Score in Patients Randomly Assigned to SORCE, an International Phase III Trial of Adjuvant Sorafenib in Renal Cell Cancer.
Journal of Clinical Oncology
10.1200/JCO.21.01090.
(In press).
|
|
|
Oza, Bhavna;
Eisen, Tim;
Stewart, Grant D;
Bex, Axel;
Royston, Patrick;
Meade, Angela;
(2023)
Reply to U. Capitanio et al.
Journal of Clinical Oncology
, 41
(3)
pp. 704-706.
10.1200/JCO.22.01124.
|
|
Parmar, MK;
Strang, J;
Choo, L;
Meade, AM;
Bird, SM;
(2017)
Randomized controlled pilot trial of naloxone-on-release to prevent post-prison opioid overdose deaths.
Addiction
, 112
(3)
pp. 502-515.
10.1111/add.13668.
|
|
|
Sirinukunwattana, K;
Domingo, E;
Richman, SD;
Redmond, KL;
Blake, A;
Verrill, C;
Leedham, SJ;
... S:CORT consortium; + view all
(2020)
Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning.
Gut
10.1136/gutjnl-2019-319866.
(In press).
|
|
|
Wasan, H;
Meade, AM;
Adams, R;
Wilson, R;
Pugh, C;
Fisher, D;
Sydes, B;
... on behalf of the COIN-B investigators; + view all
(2014)
Intermittent chemotherapy plus either intermittent or continuous cetuximab for first-line treatment of patients with KRAS wild-type advanced colorectal cancer (COIN-B): a randomised phase 2 trial.
Lancet Oncology
, 15
(6)
pp. 631-639.
10.1016/S1470-2045(14)70106-8.
|
|
